Filter posts

Buzz at BIO: Dr. Julie Gerberding, Merck

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access …

International Panel Addresses the Changing Face of Biotechnology

We live in incredible times. AIDS is now largely treatable and preventable, cancer deaths are …

#BIO2019 Fireside Chat with COWEN CEO Jeffrey Solomon

On Tuesday morning at the 2019 BIO International Convention, COWEN CEO Jeffrey Solomon sat down …

How Cultural Competence Could Help Boost Diversity in Clinical Research

According to new census population projections, the U.S. will become ‘minority white’ by 2045. During …

Leaders Weigh In: How to Combat the Diversity Divide in Biotech

It’s one thing to talk about the importance of diverse and inclusive workforces. It’s another …

Greenwood : In Drug Pricing Debate, Politicians and Patients Are Not Talking About Same Price

Summary: BIO CEO Jim Greenwood gave the following keynote address at the BIO 2019 International …

China Summit: Exploring Cross-Border Market Opportunities

Uncertainty breeds delay of innovation and volatility of markets. We are certainly seeing this play …

Gene Therapy 2.0: No Longer Science Fiction

Back in 1990, an experimental new treatment represented a bright light of hope for Ashanthi …

It Starts With One: Christopher Marshall and Biotechnology in Early Philadelphia

Christopher Marshall was a busy man. Born in Dublin, Ireland in 1709, Marshall studied in …

Welcome to #BIO2019

As BIO’s President and CEO, who proudly represented the Philadelphia suburbs in Congress for 12 …